146 related articles for article (PubMed ID: 6420703)
1. Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones.
Haglund L; Köhler C; Haaparanta T; Goldstein M; Gustafsson JA
Nature; 1984 Jan 19-25; 307(5948):259-62. PubMed ID: 6420703
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of the brain mixed function oxidase system: purification of NADPH-cytochrome P450 reductase and partial purification of cytochrome P450 from whole rat brain.
Bergh AF; Strobel HW
J Neurochem; 1992 Aug; 59(2):575-81. PubMed ID: 1629729
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain.
Anandatheerthavarada HK; Boyd MR; Ravindranath V
Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):483-8. PubMed ID: 1463452
[TBL] [Abstract][Full Text] [Related]
4. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.
Rodrigues AD; Mulford DJ; Lee RD; Surber BW; Kukulka MJ; Ferrero JL; Thomas SB; Shet MS; Estabrook RW
Drug Metab Dispos; 1995 Jul; 23(7):765-75. PubMed ID: 7587966
[TBL] [Abstract][Full Text] [Related]
6. High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein.
Fisher CW; Shet MS; Caudle DL; Martin-Wixtrom CA; Estabrook RW
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10817-21. PubMed ID: 1438282
[TBL] [Abstract][Full Text] [Related]
7. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
Yamazaki H; Ueng YF; Shimada T; Guengerich FP
Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
[TBL] [Abstract][Full Text] [Related]
10. Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase.
Guengerich FP; Martin MV; Sohl CD; Cheng Q
Nat Protoc; 2009; 4(9):1245-51. PubMed ID: 19661994
[TBL] [Abstract][Full Text] [Related]
11. Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1.
Faulkner KM; Shet MS; Fisher CW; Estabrook RW
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7705-9. PubMed ID: 7644480
[TBL] [Abstract][Full Text] [Related]
12. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
13. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities.
Bhamre S; Anandatheerathavarada HK; Shankar SK; Boyd MR; Ravindranath V
Arch Biochem Biophys; 1993 Mar; 301(2):251-5. PubMed ID: 8460938
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
15. Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity.
Hanna IH; Krauser JA; Cai H; Kim MS; Guengerich FP
J Biol Chem; 2001 Oct; 276(43):39553-61. PubMed ID: 11509577
[TBL] [Abstract][Full Text] [Related]
16. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
17. Localization of NADPH cytochrome P450 oxidoreductase in rat brain by immunohistochemistry and in situ hybridization and a comparison with the distribution of neuronal NADPH-diaphorase staining.
Norris PJ; Hardwick JP; Emson PC
Neuroscience; 1994 Jul; 61(2):331-50. PubMed ID: 7969913
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of the enzymatic activities of cytochrome P450s using recombinant flavocytochromes containing rat cytochrome b(5) fused to NADPH--cytochrome P450 reductase with various membrane-binding segments.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Arch Biochem Biophys; 2001 Jun; 390(2):215-21. PubMed ID: 11396924
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of enzymes of drug metabolism in rat liver by ultrasound and correction by heparin.
Legonkova LF; Bushma MI; Zverinsky IV; Eismont KA
Exp Toxicol Pathol; 1999 Jul; 51(4-5):360-2. PubMed ID: 10445398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
